Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: Role of fatty acid amide hydrolase

Ryan K. Butler, Gemma K. Ford, Michelle Hogan, Michelle Roche, Karen M. Doyle, John P. Kelly, David A. Kendall, Victoria Chapman, David P. Finn

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The endocannabinoid system regulates nociception and aversion and mediates fear-conditioned analgesia (FCA). We investigated the effects of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which inhibits the catabolism of the endocannabinoid anandamide and related N-acylethanolamines, on expression of FCA and fear and pain related behaviour per se in rats. We also examined associated alterations in the expression of the signal transduction molecule phospho-Akt in the periaqueductal grey (PAG) by immunoblotting. FCA was modelled by assessing formalin-evoked nociceptive behaviour in an arena previously paired with footshock. URB597 (0.3mg/kg, i.p.) enhanced FCA and increased fear-related behaviour in formalin-treated rats. Conditioned fear per se in non-formalin-treated rats was associated with increased expression of phospho-Akt in the PAG. URB597 reduced the expression of fear-related behaviour in the early part of the trial, an effect that was accompanied by attenuation of the fear-induced increase in phospho-Akt expression in the PAG. Intra-plantar injection of formalin also reduced the fear-induced increase in phospho-Akt expression. These data provide evidence for a role of FAAH in FCA, fear responding in the presence or absence of nociceptive tone, and fear-evoked increases in PAG phospho-Akt expression. In addition, the results suggest that fear-evoked activation of Akt signalling in the PAG is abolished in the presence of nociceptive tone.

Original languageEnglish (US)
Pages (from-to)83-91
Number of pages9
JournalJournal of Psychopharmacology
Volume26
Issue number1
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Periaqueductal Gray
Fear
Analgesia
Formaldehyde
Endocannabinoids
fatty-acid amide hydrolase
Nociception
Immunoblotting

Keywords

  • Akt (protein kinase B)
  • endocannabinoids
  • fatty acid amide hydrolase (FAAH)
  • fear
  • pain
  • periaqueductal grey (PAG)
  • rats

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey : Role of fatty acid amide hydrolase. / Butler, Ryan K.; Ford, Gemma K.; Hogan, Michelle; Roche, Michelle; Doyle, Karen M.; Kelly, John P.; Kendall, David A.; Chapman, Victoria; Finn, David P.

In: Journal of Psychopharmacology, Vol. 26, No. 1, 01.01.2012, p. 83-91.

Research output: Contribution to journalArticle

Butler, Ryan K. ; Ford, Gemma K. ; Hogan, Michelle ; Roche, Michelle ; Doyle, Karen M. ; Kelly, John P. ; Kendall, David A. ; Chapman, Victoria ; Finn, David P. / Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey : Role of fatty acid amide hydrolase. In: Journal of Psychopharmacology. 2012 ; Vol. 26, No. 1. pp. 83-91.
@article{12e81df13fe840f9b050b469460fecc7,
title = "Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: Role of fatty acid amide hydrolase",
abstract = "The endocannabinoid system regulates nociception and aversion and mediates fear-conditioned analgesia (FCA). We investigated the effects of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which inhibits the catabolism of the endocannabinoid anandamide and related N-acylethanolamines, on expression of FCA and fear and pain related behaviour per se in rats. We also examined associated alterations in the expression of the signal transduction molecule phospho-Akt in the periaqueductal grey (PAG) by immunoblotting. FCA was modelled by assessing formalin-evoked nociceptive behaviour in an arena previously paired with footshock. URB597 (0.3mg/kg, i.p.) enhanced FCA and increased fear-related behaviour in formalin-treated rats. Conditioned fear per se in non-formalin-treated rats was associated with increased expression of phospho-Akt in the PAG. URB597 reduced the expression of fear-related behaviour in the early part of the trial, an effect that was accompanied by attenuation of the fear-induced increase in phospho-Akt expression in the PAG. Intra-plantar injection of formalin also reduced the fear-induced increase in phospho-Akt expression. These data provide evidence for a role of FAAH in FCA, fear responding in the presence or absence of nociceptive tone, and fear-evoked increases in PAG phospho-Akt expression. In addition, the results suggest that fear-evoked activation of Akt signalling in the PAG is abolished in the presence of nociceptive tone.",
keywords = "Akt (protein kinase B), endocannabinoids, fatty acid amide hydrolase (FAAH), fear, pain, periaqueductal grey (PAG), rats",
author = "Butler, {Ryan K.} and Ford, {Gemma K.} and Michelle Hogan and Michelle Roche and Doyle, {Karen M.} and Kelly, {John P.} and Kendall, {David A.} and Victoria Chapman and Finn, {David P.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1177/0269881111413823",
language = "English (US)",
volume = "26",
pages = "83--91",
journal = "Journal of Psychopharmacology",
issn = "0269-8811",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey

T2 - Role of fatty acid amide hydrolase

AU - Butler, Ryan K.

AU - Ford, Gemma K.

AU - Hogan, Michelle

AU - Roche, Michelle

AU - Doyle, Karen M.

AU - Kelly, John P.

AU - Kendall, David A.

AU - Chapman, Victoria

AU - Finn, David P.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - The endocannabinoid system regulates nociception and aversion and mediates fear-conditioned analgesia (FCA). We investigated the effects of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which inhibits the catabolism of the endocannabinoid anandamide and related N-acylethanolamines, on expression of FCA and fear and pain related behaviour per se in rats. We also examined associated alterations in the expression of the signal transduction molecule phospho-Akt in the periaqueductal grey (PAG) by immunoblotting. FCA was modelled by assessing formalin-evoked nociceptive behaviour in an arena previously paired with footshock. URB597 (0.3mg/kg, i.p.) enhanced FCA and increased fear-related behaviour in formalin-treated rats. Conditioned fear per se in non-formalin-treated rats was associated with increased expression of phospho-Akt in the PAG. URB597 reduced the expression of fear-related behaviour in the early part of the trial, an effect that was accompanied by attenuation of the fear-induced increase in phospho-Akt expression in the PAG. Intra-plantar injection of formalin also reduced the fear-induced increase in phospho-Akt expression. These data provide evidence for a role of FAAH in FCA, fear responding in the presence or absence of nociceptive tone, and fear-evoked increases in PAG phospho-Akt expression. In addition, the results suggest that fear-evoked activation of Akt signalling in the PAG is abolished in the presence of nociceptive tone.

AB - The endocannabinoid system regulates nociception and aversion and mediates fear-conditioned analgesia (FCA). We investigated the effects of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which inhibits the catabolism of the endocannabinoid anandamide and related N-acylethanolamines, on expression of FCA and fear and pain related behaviour per se in rats. We also examined associated alterations in the expression of the signal transduction molecule phospho-Akt in the periaqueductal grey (PAG) by immunoblotting. FCA was modelled by assessing formalin-evoked nociceptive behaviour in an arena previously paired with footshock. URB597 (0.3mg/kg, i.p.) enhanced FCA and increased fear-related behaviour in formalin-treated rats. Conditioned fear per se in non-formalin-treated rats was associated with increased expression of phospho-Akt in the PAG. URB597 reduced the expression of fear-related behaviour in the early part of the trial, an effect that was accompanied by attenuation of the fear-induced increase in phospho-Akt expression in the PAG. Intra-plantar injection of formalin also reduced the fear-induced increase in phospho-Akt expression. These data provide evidence for a role of FAAH in FCA, fear responding in the presence or absence of nociceptive tone, and fear-evoked increases in PAG phospho-Akt expression. In addition, the results suggest that fear-evoked activation of Akt signalling in the PAG is abolished in the presence of nociceptive tone.

KW - Akt (protein kinase B)

KW - endocannabinoids

KW - fatty acid amide hydrolase (FAAH)

KW - fear

KW - pain

KW - periaqueductal grey (PAG)

KW - rats

UR - http://www.scopus.com/inward/record.url?scp=84856501971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856501971&partnerID=8YFLogxK

U2 - 10.1177/0269881111413823

DO - 10.1177/0269881111413823

M3 - Article

C2 - 21926424

AN - SCOPUS:84856501971

VL - 26

SP - 83

EP - 91

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

SN - 0269-8811

IS - 1

ER -